Peiyue Jiang

Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Selective silencing of placental anti-angiogenic factors in invasive trophoblasts via membrane-fusion divalent siRNA delivery for preeclampsia therapy.

Selective silencing of placental anti-angiogenic factors in invasive trophoblasts via membrane-fusion divalent siRNA delivery for preeclampsia therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 19, 2026

Testosterone disrupts trophoblast function and immune homeostasis via PTGER4/cAMP/RAP1 and ANXA1-FPR1 signaling in PCOS-complicated preeclampsia.

Testosterone disrupts trophoblast function and immune homeostasis via PTGER4/cAMP/RAP1 and ANXA1-FPR1 signaling in PCOS-complicated preeclampsia.

Journal: Cellular signalling
Published: December 19, 2025

Transcriptomics and metabolomics analysis reveal cell subpopulations of trophoblast cells associated with preeclampsia.

Transcriptomics and metabolomics analysis reveal cell subpopulations of trophoblast cells associated with preeclampsia.

Journal: Physiological genomics
Published: December 17, 2025

Mechanistic study of miR-486-5p targeting Claudin-10 in placenta accreta spectrum pathogenesis and its impact on trophoblast behavior.

Mechanistic study of miR-486-5p targeting Claudin-10 in placenta accreta spectrum pathogenesis and its impact on trophoblast behavior.

Journal: Placenta
Published: September 14, 2025

Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling.

Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca2+ signaling.

Journal: Cellular and molecular life sciences : CMLS
Published: July 11, 2025

Advanced nanoformulations of NUAK1 regulate NLRP3 inflammasome for preeclampsia management in mice.

Advanced nanoformulations of NUAK1 regulate NLRP3 inflammasome for preeclampsia management in mice.

Journal: Nature communications
Published: March 20, 2025

SOX2 promotes the glycolysis process to accelerate cervical cancer progression by regulating the expression of HK2.

SOX2 promotes the glycolysis process to accelerate cervical cancer progression by regulating the expression of HK2.

Journal: Acta histochemica
Published: September 06, 2024

EFNA1 promotes the tumorigenesis and metastasis of cervical cancer by phosphorylation pathway and epithelial-mesenchymal transition.

EFNA1 promotes the tumorigenesis and metastasis of cervical cancer by phosphorylation pathway and epithelial-mesenchymal transition.

Journal: Acta histochemica
Published: July 30, 2024

SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis.

SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis.

Journal: Anticancer research
Published: March 13, 2024

Pregnancy induced hypertension and umbilical cord blood DNA methylation in newborns: an epigenome-wide DNA methylation study.

Pregnancy induced hypertension and umbilical cord blood DNA methylation in newborns: an epigenome-wide DNA methylation study.

Journal: BMC pregnancy and childbirth
Published: October 02, 2023

Preeclampsia in pregnant women with polycystic ovary syndrome: risk factor analysis based on a retrospective cohort study.

Preeclampsia in pregnant women with polycystic ovary syndrome: risk factor analysis based on a retrospective cohort study.

Journal: Ginekologia polska
Published: October 20, 2022

The role of ferritin and iron dextran in exacerbating preeclampsia in an L-NAME-treated rat model.

The role of ferritin and iron dextran in exacerbating preeclampsia in an L-NAME-treated rat model.

Journal: Annals of translational medicine
Published: June 09, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026